Taro-Palbociclib 100 mg

TARO-PALBOCICLIB 100 MG is an oral tablet used for specific therapeutic purposes. This medication is manufactured by Taro Pharmaceuticals Inc. in Canada.

TARO-PALBOCICLIB 100 MG is a medication often used in the management of certain types of cancer. It is typically prescribed as part of a treatment plan that may include other therapies. The primary use of palbociclib is to slow the progression of cancer cells, making it a key component in the treatment of advanced or metastatic breast cancer in combination with other drugs.

Common effects of TARO-PALBOCICLIB 100 MG may include fatigue, nausea, and a decrease in blood cell counts. Some individuals might experience hair loss or infections. It is important to discuss any persistent or severe side effects with a healthcare provider.

TARO-PALBOCICLIB 100 MG should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may affect the immune system, so regular monitoring is advisable.

TARO-PALBOCICLIB 100 MG may interact with certain medications, including those that affect liver enzymes. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution.